PolyTherics applies precision chemistry to extend the duration of action of protein and peptide drugs. This can improve efficacy and patients require fewer injections, reducing the cost of treatment and improving compliance.
The Company has three proprietary technologies for attaching one or more molecules of poly (ethylene glycol) (PEG) to any therapeutic peptide or protein to slow its elimination from the body. PolyTherics’ methods of PEGylation add PEG to a specific site producing a more homogeneous product than traditional PEGylation technologies. The Company’s technologies are:
- TheraPEG™ - PEGylation across one or more disulfide bonds
- HiPEG™ - PEGylation at a histidine tag
- CyPEG™ - PEGylation at the thiol group of free cysteine
www.polytherics.com